ERBB2 and colorectal cancer: It has been reported that miR-331-3p targets HER2 through the PI3K/Akt and extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) pathways, thereby inhibiting the proliferation of colorectal cancer cells [97].